Skip to main content
Premium Trial:

Request an Annual Quote

Greenwood Genetic Center Taps Cartagenia’s BenchLab for Clinical Data Analysis

Premium

Cartagenia said this week that Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory testing, his licensed its BenchLab next-generation sequencing and copy number variant analysis software solutions.

Cartagenia's BenchLab NGS product is designed to interpret data from gene panels as well as exome- and whole-genome sequencing, and to generate clinical reports based on the results. Its BenchLab CNV solution helps labs use microarray testing for prenatal diagnosis.

Greenwood’s researchers will use the products to sort, filter, and organize their data and “aid in the process of interpreting the genetic alterations,” Mike Friez, Greenwood's director of diagnostic laboratories, said in a statement.

Other customers of Cartagenia’s products include CombiMatrix, an Irvine, Calif.-based molecular diagnostics firm (BI 11/2/2012).

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.